Cargando…

Risk of hypoglycaemia in type 2 diabetes patients under different insulin regimens: a primary care database analysis

Aims: To compare rates and predictors of documented hypoglycaemia in type 2 diabetes patients treated with either basal insulin supported oral therapy (BOT), conventional therapy (CT) or supplementary insulin therapy (SIT) in primary care. Methods: Data from 10,842 anonymous patients (mean age ± SD:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kostev, Karel, Dippel, Franz W., Rathmann, Wolfgang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	German Medical Science GMS Publishing House 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4311049/ https://www.ncbi.nlm.nih.gov/pubmed/25698911 http://dx.doi.org/10.3205/000205

Ejemplares similares

Glycemic control after initiating basal insulin therapy in patients with type 2 diabetes: a primary care database analysis
por: Kostev, Karel, et al.
Publicado: (2015)

Fracture risk in patients with type 2 diabetes under different antidiabetic treatment regimens: a retrospective database analysis in primary care
por: Pscherer, S, et al.
Publicado: (2016)

Association of glucose-lowering drugs with incident stroke and transient ischaemic attacks in primary care patients with type 2 diabetes: disease analyzer database
por: Rathmann, Wolfgang, et al.
Publicado: (2022)

Correction to: Association of glucose‑lowering drugs with incident stroke and transient ischaemic attacks in primary care patients with type 2 diabetes: disease analyzer database
por: Rathmann, Wolfgang, et al.
Publicado: (2022)

Routine care for people with newly diagnosed type 2 diabetes before and during the SARS-CoV-2 pandemic – results from the German Disease Analyzer database
por: Kowall, Bernd, et al.
Publicado: (2023)

Incidence of newly diagnosed diabetes after Covid-19
por: Rathmann, Wolfgang, et al.
Publicado: (2022)

Diabetes incidence before and after COVID-19 vaccination – Results from the German Disease Analyzer database
por: Kowall, Bernd, et al.
Publicado: (2023)

Insulin Hypoglycæmia
Publicado: (1948)

Changes in Glycemic Control and Body Weight After Initiation of Dapagliflozin or Basal Insulin Supported Oral Therapy in Type 2 Diabetes: A Primary Care Database Study
por: Kostev, Karel, et al.
Publicado: (2017)

Association between type 2 diabetes and chronic low back pain in general practices in Germany
por: Jacob, Louis, et al.
Publicado: (2021)

Type 1 diabetes incidence in children and adolescents during the COVID-19 pandemic in Germany
por: van den Boom, Louisa, et al.
Publicado: (2022)

Effects of the COVID‐19 pandemic on clinically diagnosed psychiatric disorders in persons with type 2 diabetes
por: Kowall, Bernd, et al.
Publicado: (2022)

Are we missing hypoglycaemia? Elderly patients with insulin-treated diabetes present to primary care frequently with non-specific symptoms associated with hypoglycaemia
por: Hope, Suzy V., et al.
Publicado: (2018)

Hypoglycaemia in Type 2 diabetes
por: Amiel, S A, et al.
Publicado: (2008)

Cost of severe hypoglycaemia in patients with type 1 diabetes in Spain and the cost-effectiveness of insulin lispro compared with regular human insulin in preventing severe hypoglycaemia
por: Reviriego, J, et al.
Publicado: (2008)

Reduced hypoglycaemia using liver‐targeted insulin in individuals with type 1 diabetes
por: Weinstock, Ruth S., et al.
Publicado: (2022)

Prevalence of high-risk cardiovascular patients with therapy-resistant hypercholesterolemia
por: Kostev, Karel, et al.
Publicado: (2017)

Hypoglycaemia is reduced with use of inhaled Technosphere(®) Insulin relative to insulin aspart in type 1 diabetes mellitus
por: Seaquist, E. R., et al.
Publicado: (2019)

A meta‐analysis of rate ratios for nocturnal confirmed hypoglycaemia with insulin degludec vs. insulin glargine using different definitions for hypoglycaemia
por: Heller, S., et al.
Publicado: (2015)

Changes in HbA1c, body weight, and systolic blood pressure in type 2 diabetes patients initiating dapagliflozin therapy: a primary care database study
por: Scheerer, Markus F, et al.
Publicado: (2016)

Evaluation of Hypoglycaemia with Non-Invasive Sensors in People with Type 1 Diabetes and Impaired Awareness of Hypoglycaemia
por: Elvebakk, Ole, et al.
Publicado: (2018)

Severe hypoglycaemia in adults with insulin‐treated diabetes: impact on healthcare resources
por: Heller, S. R., et al.
Publicado: (2015)

Cost comparison of insulin glargine with insulin detemir in a basal-bolus regime with mealtime insulin aspart in type 2 diabetes in Germany
por: Pscherer, Stefan, et al.
Publicado: (2010)

Adherence to insulin treatment in insulin-naïve type 2 diabetic patients initiated on different insulin regimens
por: Yavuz, Dilek Gogas, et al.
Publicado: (2015)

The impact of hypoglycaemia awareness status on regional brain responses to acute hypoglycaemia in men with type 1 diabetes
por: Dunn, Joel T., et al.
Publicado: (2018)

Limited impact of impaired awareness of hypoglycaemia and severe hypoglycaemia on the inflammatory profile of people with type 1 diabetes
por: Ali, Namam, et al.
Publicado: (2020)

Impaired awareness of hypoglycaemia in women with type 1 diabetes in pregnancy: Hypoglycaemia fear, glycaemic and pregnancy outcomes
por: Bahrami, Jasmine, et al.
Publicado: (2022)

Hypoglycaemia and accident risk in people with type 2 diabetes mellitus treated with non-insulin antidiabetes drugs
por: Signorovitch, J E, et al.
Publicado: (2013)

Does hypoglycaemia affect the improvement in QoL after the transition to insulin in people with type 2 diabetes?
por: Wieringa, T. H., et al.
Publicado: (2017)

Glycaemic control and hypoglycaemia burden in patients with type 2 diabetes initiating basal insulin in Europe and the USA
por: Mauricio, Dídac, et al.
Publicado: (2017)

Comment on Mizokami-Stout et al. The Contemporary Prevalence of Diabetic Neuropathy in Type 1 Diabetes: Findings From the T1D Exchange. Diabetes Care 2020;43:806–812
por: Kostev, Karel
Publicado: (2020)

Duration of type 2 diabetes does not appear to moderate hypoglycaemia rate with insulin degludec versus insulin glargine U100
por: Alexopoulos, Anastasia‐Stefania, et al.
Publicado: (2021)

Metabolic control and hypoglycaemia in people with type 1 diabetes: insulin pump therapy vs. intensified insulin therapy in an unselected cohort in routine care
por: Kramer, Guido, et al.
Publicado: (2021)

Fear of hypoglycaemia and self-management in type 1 diabetes
por: Ahola, Aila J., et al.
Publicado: (2016)

Health status and hypoglycaemia with insulin degludec versus insulin glargine: a 2-year trial in insulin-naïve patients with type 2 diabetes
por: Rodbard, H W, et al.
Publicado: (2014)

Hypoglycaemia in adults with insulin‐treated diabetes in the UK: self‐reported frequency and effects
por: Frier, B. M., et al.
Publicado: (2015)

Making surgical wards safer for patients with diabetes: reducing hypoglycaemia and insulin errors
por: Singh, Aminder, et al.
Publicado: (2018)

Approach to assessing the economic impact of insulin‐related hypoglycaemia using the novel Local Impact of Hypoglycaemia Tool
por: Parekh, W. A., et al.
Publicado: (2015)

Concentrations of the Stress Hormone Copeptin Increase upon Hypoglycaemia in Patients with Type 1 Diabetes Dependent of Hypoglycaemia Awareness
por: Seelig, Eleonora, et al.
Publicado: (2013)

Author Correction: Evaluation of Hypoglycaemia with Non-Invasive Sensors in People with Type 1 Diabetes and Impaired Awareness of Hypoglycaemia
por: Elvebakk, Ole, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_kgo9hubmsrd1bbgaqvh4lvrki3